Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

NCT07390435 | Recruiting

• 1 other identifier: SC32S
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. These factors may include income, education, employment, housing, social supports, and experiences with discrimination or stress. Participation will help researchers better understand barriers to participating in clinical trials and access to health care.

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

• To evaluate the feasibility of collecting comprehensive sociodemographic data via a standardized SDoH Questionnaire among participants being screened and consented to a CCTG trial and participants already enrolled in a CCTG trial

  12 months

Secondary Outcomes (1)

• To assess the acceptability of this SDoH questionnaire to participants.

  12 months

Interventions

Social Determinants of Health Questionnaire OTHER

This study will use a standardized SDoH Questionnaire to collect the required sociodemographic data

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

This study is designed to include participants who have consented to a CCTG clinical trial. If a patient consents to a CCTG trial but does not enroll, they will remain eligible for SC.32S.

You may qualify if:

• Adults (≥18 years) who are either:
• Currently being screened and consented to a CCTG trial (prospective).
• Already enrolled in an ongoing CCTG trial and still under follow-up (retrospective).

You may not qualify if:

• Participants already enrolled or expected to enroll in a CCTG trial that is also collecting the SDoH Questionnaire.

Sponsors & Collaborators

• Canadian Cancer Trials Group: lead

Study Sites (1)

Regional Health Authority B, Zone 2

Saint John, New Brunswick, E2L 4L2, Canada

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Leah Lambert

  BCCA - Vancouver Cancer Centre, Vancouver, BC Canada

  STUDY CHAIR

• Michael McKenzie

  BCCA - Vancouver Cancer Centre

  STUDY CHAIR

Central Study Contacts

Anna Johnson

CONTACT

613-533-6430; ajohnson@ctg.queensu.ca

Mariam Jafri

CONTACT

613-533-6430; mjafri@ctg.queensu.ca

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: OTHER
• Sponsor Type: NETWORK
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 29, 2026
• First Posted: February 5, 2026
• Study Start (Estimated): June 30, 2026
• Primary Completion (Estimated): January 31, 2027
• Study Completion (Estimated): June 30, 2027
• Last Updated: May 6, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)